MS Month 2018: Care and research at The Neuro
May is Multiple Sclerosis (MS) Month. Laboratory and clinical studies related to MS involve about 50 members of The Neuro鈥檚 staff. They study the disease in all its aspects and at every stage with the help of the most advanced brain imaging technology and the latest cell biology techniques.
MS Awareness Month 2017
The Montreal Neurological Institute and Hospital (The Neuro) is home to Canada鈥檚 first multiple sclerosis (MS) clinic, and MS research and treatment has been a major focus at The Neuro for many years. The MS clinic employs a highly specialized staff who have access to the latest research data and methods of treatment. It is a clinic where innovation and progress are paramount.
Breakthrough in MS treatment
Drug shown to reduce new attacks/symptom progression in some patients
In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.
Team led by MNI researcher receive $6.1 million to study MS
A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis.
The International Progressive MS Alliance has awarded three $6.1 million Collaborative Network Award grants for a total investment of $18.4 million toward accelerating the pace of progressive MS research. More than 2.3 million people worldwide live with MS and more than one million of those living with the disease have progressive MS.
May 2016 - Multiple Sclerosis Awareness Month
May 2016 - Multiple Sclerosis Awareness Month听
May - Multiple Sclerosis Awareness Month
The Montreal Neurological Institute and Hospital 鈥� The Neuro at 平特五不中 and the MUHC has Canada鈥檚 oldest MS clinic but is always innovating - striving for progress and better treatments for patients.
What鈥檚 new in MS at The Neuro
